ABSTRACT
INTRODUCTION
In the present era, an individual has to face lots of difficulties in following Dinacharya (daily regime) and Ritucharya (seasonal regime) described in Ayurveda. Due to over-industrialization and changed lifestyle, one constantly meets with various pollutants. Increased use of junk food and Viruddhahara all ultimately result in Dhatudaurbalya, which causes sensitization toward allergens as well as antibodies and produce various types of allergic diseases, like urticaria (Sheetapitta). 1 Urticaria is a type I hypersensitivity reaction that is manifested because of exposure to such allergens. Epidemiology of urticaria is increasing now days due to industrialization and agriculture. Vata and Kapha are two Doshas, which are primarily disturbed in this disease. In combination with Pitta they create redness, swelling, and itching on the skin, and although the disease is not life-threatening, it makes the patient troubled due to its appearance, severe itching disturbing routine, and its nature susceptible to be chronic. Urticaria affects around 20% of people at some point in their lifetime. 2 In some cases, the disorder is relatively mild, recurrent, and frustrating for both the patient and the physician. The discomfort and distress caused by urticaria can lead to serious impairment of quality of life, almost comparable to that experienced by patients with cardiovascular disease. Modern medicine possesses no remedy for permanent cure, but only remission of the disease can be achieved by administering the medicine. Patients have to take those medicines for long time, which have some unwanted side-effects. Ayurveda can provide better and permanent management for Sheetapitta.
AIM
To observe safety and efficacy of Haridrakhanda 3 in the patients suffering from Sheetapitta (urticaria) in the clinical setting.
MATERIALS AND METHODS
An observational retrospective cohort design was adopted. Thirty-nine patients of either sex, of age between 18 and 70 years, were selected from the OPD of RARIND, Mandi, Himachal Pradesh (a research institute under CCRAS, Ministry of AYUSH, New Delhi, India) during March 2013 to June 2014. The patients who were treated with Haridrakhanda for Sheetapitta [urticaria with recurrent symptoms of itching (Kandu), reddening, flares, and burning sensation] were studied. Many patients have been successfully treated with the study drug during this period but only the patients who have shown 100% drug compliance with proper documentation of clinical criteria during treatment were considered for the study.
As the study was done by data mining of old cases of the institute's OPD, consent was not felt necessary and ethical committee of our institute granted consent waiver.
Study Intervention
Haridrakhanda manufactured by the Indian Medicines Pharmaceutical Corporation Limited was prescribed as oral medication to each participant in the dose of 3 gm twice a day with milk for 14 days.
Outcome Measure
The assessment was done by evaluating the changes in the signs and symptoms (Ayurveda subjective parameter) during and after treatment, and scoring system was adopted for easier statistical analysis of the result. The signs and symptoms of Sheetapitta included in scoring were Varati Dashta Samsthana Shotha (inflammation rash, like an insect bite), Kandubahula (severe itching), Todabahula (severe pricking pain), Raga (redness of skin), Vidaha (burning sensation), Chhardi (vomiting), and Jwara (fever) with grading of 0 (absent), 1 (mild), 2 (moderate), and 3 (severe).
Data Analysis
The information gathered based on the above observations was subjected to statistical analysis using Graph Pad Prism Software, version 6.01. Student's paired t-test was applied for statistical improvement analysis in the Ayurveda severity score parameter.
Drug Review
Haridrakhanda is composed of 25 contents as depicted in Table 1 . Its main content is Harida (turmeric), which has potent Kushthagna (demolishing skin diseases) and Varnya (complexion enhancing) properties. 4 Hence,
Haridrakhanda was selected for present study with cow milk as an adjuvant drink. 5 Case studies have been published showing promising results of Haridrakhanda in the management of urticaria.
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RESULTS
No concomitant medication was used during the study, and no any adverse effect was reported or noticed during Tables 2 and 3 .
DISCUSSION
Maximum improvement was seen in Toda followed by Kandubahula and Varati Dashta Samsthana Shotha. The main content of Haridra khanda is Haridra (turmeric), which is a potent antiallergic drug, recommended in various allergic conditions including skin allergies like urticaria, itching, blisters, etc. 31 As it was an observational study on patients of Sheetapitta, being treated in usual clinical setting of OPD of RARIND, Mandi, neither any randomization was done nor were any confounding factors controlled. The medicine was made available to patients from OPD of RARIND, Mandi. Further, no deterioration was noted in the subsequent follow-up of the patients, but many patients do come with recurrence of mild symptoms of urticaria after 4 to 5 months requiring repeat of the same treatment, but the data were not collected and hence were not taken in the study for statistical analysis.
CONCLUSION
The results of the treatment were encouraging and no side-effect was noted clinically during the therapy. This study may be considered as a primary evidence for further extensive studies and clinical research on large sample size for further evaluation. 
